J Liver Cancer.  2018 Sep;18(2):94-102. 10.17998/jlc.18.2.94.

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Affiliations
  • 1Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. drsmyoon@amc.seoul.kr

Abstract

With recent remarkable technological advances in radiation therapy, stereotactic body radiation therapy (SBRT) is regarded as an alternative treatment option for hepatocellular carcinoma (HCC) that is not suitable for curative treatment. Several prospective and retrospective studies on the use of SBRT in patients with HCC showed promising results. Furthermore, on-going prospective studies are examining the role of SBRT as a single ablative modality or a combination treatment in patients with HCC. Here, we summarize previous studies and recent updates and discuss the future perspectives of SBRT for HCC.

Keyword

Carcinoma, Hepatocellular; Radiation

MeSH Terms

Carcinoma, Hepatocellular*
Humans
Prospective Studies
Retrospective Studies
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr